Survival of Patients With Cancer With DPYD Variant Alleles and Dose-Individualized Fluoropyrimidine Therapy—A Matched-Pair Analysis
Journal of Clinical Oncology · 2023
DOI: 10.1200/jco.22.02780 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Clinical Oncology, 2023. Verfasst von Jonathan E Knikman und 23 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Fluorouracil, Neoplasms. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
Outcome of DPYD variant allele carriers treated with dose-individualized fluoropyrimidine therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
- Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
- Biometrics Department, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
- Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, Leiden, the Netherlands.
- Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.
- Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.
ORCID-Profile: Jonathan E Knikman, Tycho A Wilting, Marta Lopez-Yurda, Geert-Jan Creemers, Ron H J Mathijssen, Johanneke E A Portielje, Liselot Valkenburg-van Iersel, Arnold Baars, Jesse J Swen, Hans Gelderblom, Jos H Beijnen, Henk-Jan Guchelaar
Zitieren
APA
Knikman, J. E., Wilting, T. A., Lopez-Yurda, M., Henricks, L. M., Lunenburg, C. A. T. C., de Man, F. M., Meulendijks, D., Nieboer, P., Droogendijk, H. J., Creemers, G. J., Mandigers, C. M. P. W., Imholz, A. L. T., Mathijssen, R. H. J., Portielje, J. E. A., Valkenburg-van Iersel, L., Vulink, A., van der Poel, M. H. W., Baars, A., Swen, J. J., …, & Cats, A. (2023). Survival of Patients With Cancer With DPYD Variant Alleles and Dose-Individualized Fluoropyrimidine Therapy—A Matched-Pair Analysis. Journal of Clinical Oncology. https://doi.org/10.1200/jco.22.02780
Vancouver
Knikman JE, Wilting TA, Lopez-Yurda M, Henricks LM, Lunenburg CATC, de Man FM, et al. Survival of Patients With Cancer With DPYD Variant Alleles and Dose-Individualized Fluoropyrimidine Therapy—A Matched-Pair Analysis. Journal of Clinical Oncology. 2023. doi:10.1200/jco.22.02780
BibTeX
@article{Knikman2023,
author = {Knikman, Jonathan E and Wilting, Tycho A and Lopez-Yurda, Marta and Henricks, Linda M and Lunenburg, Carin A T C and de Man, Femke M and Meulendijks, Didier and Nieboer, Peter and Droogendijk, Helga J and Creemers, Geert-Jan and Mandigers, Caroline M P W and Imholz, Alexander L T and Mathijssen, Ron H J and Portielje, Johanneke E A and Valkenburg-van Iersel, Liselot and Vulink, Annelie and van der Poel, Marlene H W and Baars, Arnold and Swen, Jesse J and Gelderblom, Hans and Schellens, Jan H M and Beijnen, Jos H and Guchelaar, Henk-Jan and Cats, Annemieke},
title = {Survival of Patients With Cancer With DPYD Variant Alleles and Dose-Individualized Fluoropyrimidine Therapy—A Matched-Pair Analysis},
journal = {Journal of Clinical Oncology},
year = {2023},
doi = {10.1200/jco.22.02780}
}
EUVIMED